Finanzas de Akso Health Group (AHG)AHGAkso Health Group

Evaluating the bottom line, Akso Health Group maintains a gross margin of 8.90%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -20.54%, while the net margin is -18.59%. These profitability ratios, combined with a Return on Equity (ROE) of -68.03%, provide a clear picture of how effectively AHG converts its operational activities into shareholder value.

In the context of the broader market, AHG competes directly with industry leaders such as LUXE and REAL. With a market capitalization of $1.21B, it holds a significant position in the sector. When comparing efficiency, AHG's gross margin of 8.90% stands against LUXE's 48.11% and REAL's 74.36%. Such benchmarking helps identify whether Akso Health Group is trading at a premium or discount relative to its financial performance.

The stock has a negative P/E ratio of -10.97, indicating losses, and a forward P/E of 0, suggesting no expected earnings growth. The price-to-sales ratio is extremely high at 75.56, which raises concerns about valuation.